targeting the mechanisms of treatment resistance in cancer with Nicholas  Goldner | 222

0 意见· 09/26/23

Nicholas Goldner, PhD, is the CEO and co-founder of resistanceBio, where he leads a mission to outsmart cancer by developing innovative therapies targeting treatment resistance mechanisms. He also serves as a venture partner at Pioneer... Source

显示更多

 0 注释 sort   排序方式


下一个